Results 1 to 10 of about 861,404 (347)

Platelet Transfusion in Patients With Sepsis and Thrombocytopenia: A Propensity Score-Matched Analysis Using a Large ICU Database

open access: yesFrontiers in Medicine, 2022
PurposeSepsis with thrombocytopenia is highly prevalent in critically ill intensive care unit (ICU) patients and is associated with adverse outcomes. Platelet transfusion is the primary treatment of choice. However, evidence for the beneficial effects of
Shuangjun He   +4 more
doaj   +2 more sources

Platelet Transfusion: And Update on Challenges and Outcomes

open access: yesJournal of Blood Medicine, 2020
Pilar Solves Alcaina Blood Bank, Hematology Service, Hospital Universitari I Politècnic La Fe, Valencia, CIBERONC, Instituto Carlos III, Madrid, SpainCorrespondence: Pilar Solves AlcainaBlood Bank, Hematology Service, Hospital Universitari I Polit&
Solves Alcaina P
doaj   +2 more sources

Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia.

open access: yesNew England Journal of Medicine, 2023
BACKGROUND Transfusion guidelines regarding platelet-count thresholds before the placement of a central venous catheter (CVC) offer conflicting recommendations because of a lack of good-quality evidence.
Floor L F van Baarle   +19 more
semanticscholar   +3 more sources

ABO-identical versus incompatible platelet transfusion in patients with intracranial hemorrhage. [PDF]

open access: yesPLoS ONE
BackgroundPatients with spontaneous and traumatic intracranial hemorrhage (ICH) are frequently transfused platelets to treat thrombocytopenia, platelet function defects, and reverse antiplatelet drugs.
Lauren K Dunn   +7 more
doaj   +2 more sources

Platelet Transfusion

open access: yesCurrent Opinion in Hematology
Purpose of review Platelet transfusions, used as prophylaxis or treatment for bleeding, are potentially life-saving. In many countries, demand for platelet transfusion is rising. Platelets are a limited and costly resource, and it is vital that they are used appropriately.
Agarwal A, Khan AI, Anwer F.
europepmc   +4 more sources

Mechanism and transfusion strategy of immunogenic platelet transfusion refractoriness

open access: yesZhongguo shuxue zazhi, 2022
Platelet transfusion is an irreplaceable method to treat patients with platelet reduction in Hematology Department and Oncology Department. However, immunogenic platelet transfusion refractoriness is a huge challenge to patients who require repeatedly ...
Juan SAI, Li TIAN
doaj   +1 more source

Transfusion effect of 0.5-dose of apheresis platelet in pediatric patients

open access: yesZhongguo shuxue zazhi, 2023
Objective To investigate the transfusion effect of 0.5-dose of apheresis platelet in pediatric patients. Methods A total of 195 children who underwent 0.5-dose platelet transfusion from August 2021 to June 2022 were enrolled, and the platelet count ...
Lijuan QIU   +3 more
doaj   +1 more source

Two-year outcomes following a randomised platelet transfusion trial in preterm infants

open access: yesArchives of Disease in Childhood, 2023
Objective Assess mortality and neurodevelopmental outcomes at 2 years of corrected age in children who participated in the PlaNeT-2/MATISSE (Platelets for Neonatal Transfusion - 2/Management of Thrombocytopenia in Special Subgroup) study, which reported ...
C. Moore   +21 more
semanticscholar   +1 more source

Extent of transfusion support in a developing country in managing a bleeding acute myeloid leukemia patient with platelet transfusion refractoriness

open access: yesAsian Journal of Transfusion Science, 2021
Conventional platelet transfusion may not be adequate to deal with platelet transfusion refractoriness (PTR), and therefore human leukocyte antigen (HLA) or human platelet antigen (HPA) matched and platelet crossmatch compatible units are recommended ...
Gayathiri K Chellaiya   +5 more
doaj   +1 more source

Executive Summary of Recommendations and Expert Consensus for Plasma and Platelet Transfusion Practice in Critically Ill Children: From the Transfusion and Anemia EXpertise Initiative—Control/Avoidance of Bleeding (TAXI-CAB)

open access: yesPediatric Critical Care Medicine, 2022
Supplemental Digital Content is available in the text. OBJECTIVES: Critically ill children frequently receive plasma and platelet transfusions. We sought to determine evidence-based recommendations, and when evidence was insufficient, we developed expert-
Marianne E. Nellis   +28 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy